Is this your app? Claim this page to add your own description, links and contact info. It's free. →

Appropriate Use Criteria (AUC)  for Cardiac Radionuclide Imaging

Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging at Mac App Store analyse

Astellas
6,416 ratings · Power index: 260
Version 4
Size 4.57 Mb
Updated 9 years ago
Released 14 Sep 2010

How do you feel about this app?

Screenshots

Description

This free application will help guide you through the process of determining whether cardiac radionuclide imaging (RNI) is appropriate for your patient, based on the 2009 Appropriate Use Criteria, a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. By entering information about your patient, you will see on a scale of 1-9 if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI, per the criteria. Some of the questions that may be asked with regard to your patient include: - Is the patient within 3 months of acute coronary syndrome (ACS)? - Has the patient undergone prior revascularization? - Has the patient undergone prior imaging? - Does the patient have ischemic-equivalent symptoms? This application was developed using the guidance for AUC described in Hendel RC, et al. J Am Coll Cardiol. 2009;53:2201-2229. Repurposed by permission from Elsevier Inc. Please note: these criteria are intended to provide guidance for clinicians, and are not intended to serve as substitutes for sound clinical judgment and practice experience, nor do they provide information regarding the technical aspects of imaging or delineate training/performance requirements. Additionally, they are not intended to serve as any indication (either approval or denial) of medical insurance coverage for the described tests. The content or material Astellas Pharma US, Inc. provides herein is for informational purposes only and should not be construed as medical, legal, financial, investment, or other professional advice or opinion.

Estimates

Monthly Downloads > 5.72k
Est. Revenue ~ $2.34k

Availability

Devices

iPhone3GS iPadWifi iPad3G iPhone4 iPodTouchThirdGen iPodTouchFourthGen iPad2Wifi iPad23G iPhone4S iPadThirdGen iPadThirdGen4G iPhone5 iPodTouchFifthGen iPadFourthGen iPadFourthGen4G iPadMini iPadMini4G iPhone5c iPhone5s iPadAir iPadAirCellular iPadMiniRetina iPadMiniRetinaCellular iPhone6 iPhone6Plus iPadAir2 iPadAir2Cellular iPadMini3 iPadMini3Cellular iPodTouchSixthGen iPhone6s iPhone6sPlus iPadMini4 iPadMini4Cellular iPadPro iPadProCellular iPadPro97 iPadPro97Cellular iPhoneSE iPhone7 iPhone7Plus iPad611 iPad612 iPad71 iPad72 iPad73 iPad74

Pricing by country

Country Price
USA free